MDM2 SNP 285 is Associated with Reduced Lung Cancer Risk in Bangladeshi Population

Area of Science:

• Genetics
• Oncology
• Molecular Biology

Background:

• The MDM2 gene, a key negative regulator of the tumor suppressor p53, plays a role in cancer development.
• Genetic variations in MDM2 may influence susceptibility to lung cancer.
• Previous studies have explored MDM2 polymorphisms and lung cancer risk with varying results.

Purpose of the Study:

• To investigate the association between two MDM2 gene single nucleotide polymorphisms (SNPs), rs117039649 (SNP 285 G>C) and rs769412 (SNP 354 A>G), and lung cancer risk.
• To evaluate these associations within the Bangladeshi population.

Main Methods:

• A case-control study was conducted with 126 lung cancer patients and 133 healthy controls from Bangladesh.
• Genotyping of MDM2 SNPs was performed using the Polymerase Chain Reaction-Restriction Fragment Length Polymorphism (PCR-RFLP) method.
• Statistical analyses, including multivariate logistic regression, were employed to assess the associations.

Main Results:

• MDM2 SNP 285 G>C (rs117039649) was found to significantly decrease the risk of lung cancer (OR = 0.29, p<0.005).
• This protective effect of SNP 285 was consistent across subgroups including younger individuals, males, overweight individuals, and smokers.
• No significant association was observed between MDM2 SNP 354 A>G (rs769412) and lung cancer risk in the studied population (p>0.05).

Conclusions:

• MDM2 SNP 285 G>C (rs117039649) is a potential protective factor against lung cancer development in the Bangladeshi population.
• MDM2 SNP 354 A>G (rs769412) does not appear to be associated with lung cancer risk in this population.
• Further research may elucidate the precise mechanisms underlying the protective role of MDM2 SNP 285.